Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance in H1 2025 met expectations, with revenue of 1.496 billion yuan (down 4.03% year-on-year) and a net profit of 167 million yuan (down 9.51% year-on-year). Q2 revenue was 758 million yuan (up 0.87% year-on-year) and net profit was 76 million yuan (down 9.30% year-on-year) [4] - The company has seen a significant increase in overseas revenue, which reached 97 million yuan (up 208.97% year-on-year), following acquisitions that enhanced its overseas channels and customer resources. The company is also planning to list on the Hong Kong Stock Exchange to further boost its overseas business expansion capabilities [4] - The company is focusing on optimizing its product categories and increasing the proportion of self-developed products, which has improved its profitability. The gross profit margin for H1 2025 was 52.49% (up 1.82 percentage points) [4] Financial Summary - For 2025, the company is projected to achieve a net profit of 376 million yuan, with earnings per share (EPS) of 1.80 yuan. The price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are expected to be 22.9, 18.1, and 14.2 respectively [4][6] - The company plans to distribute a dividend of 122 million yuan in mid-2025, indicating a commitment to returning value to shareholders [6] - The company has a strong focus on the home medical device sector, benefiting from the aging population and increasing demand for healthcare products. The revenue from hearing aids has grown over 20% year-on-year in H1 2025 [6]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's Q2 net profit attributable to shareholders increased by 18.3% year-on-year, and Q3 performance is expected to accelerate further [2] - In H1 2025, the company achieved total revenue of 5.17 billion yuan, up 7% year-on-year, and a net profit of 1.43 billion yuan, up 11% year-on-year [2] - The growth in Q2 was driven by the recovery in the excavator sector and increased market share in the mid-to-large excavator pump and valve market [2] - The company has developed over 50 new products in the linear actuator segment, with nearly 300 new customers, which is expected to contribute to performance growth [2] Financial Performance - The gross margin for Q2 2025 improved by 0.9 percentage points year-on-year to 44%, while the net profit margin increased by 1.8 percentage points to 29.6% [3] - The company's expense control remains robust, with sales, management, financial, and R&D expense ratios showing stable trends [3] - The report forecasts net profits for 2025-2027 at 2.87 billion, 3.41 billion, and 4.14 billion yuan respectively, with corresponding P/E ratios of 41, 34, and 28 times [4] Strategic Developments - The establishment of a hydraulic component production base in Mexico is expected to enhance the company's access to high-end customers in North America [4] - The company is expanding its product offerings in the linear actuator segment, focusing on high-quality and innovative solutions [4] - The report highlights the company's proactive approach in the electrification of construction machinery components, with electric cylinders already being implemented in high-end products [4]

2025 年 08 月 26 日 赛轮轮胎 (601058) ——Q2 产销再创新高，盈利受关税、销售研发及所得税费用 影响，有所下滑 报告原因：有业绩公布需要点评 | 投资要点： | | --- | zhaowq@swsresearch.com 财务数据及盈利预测 | | 2024 | 2025H1 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 31,802 | 17,587 | 37,956 | 42,682 | 44,713 | | 同比增长率（%） | 22.4 | 16.1 | 19.3 | 12.5 | 4.8 | | 归母净利润（百万元） | 4,063 | 1,831 | 4,069 | 4,793 | 5,276 | | 同比增长率（%） | 31.4 | -14.9 | 0.2 | 17.8 | 10.1 | | 每股收益（元/股） | 1.26 | 0.56 | 1.24 | 1.46 | 1.60 | | 毛利率（%） | 27.6 | 24.5 | 25.9 | 25.6 ...

证券研究报告 2025 年 08 月 26 日 湘财证券研究所 公司研究 保利发展（600048.SH） 25H1 业绩承压，销售拿地规模领先 相关研究： 根据公司发布的 2025 年半年报，公司今年上半年实现营业总收入 1168.57 亿元（同比-16.08%），实现归母净利润 27.11 亿元（同比-63.47%），与业绩 快报基本保持一致。单季度看，2025Q2 营业总收入、归母净利润分别为 625.85 亿元、7.6 亿元，同比分别为-30.07%、-85.38%，环比分别为+15.32%、 -61.04%。 ❑ 销售：加快库存去化，销售聚焦核心城市 ❑ 投资：补充核心城市土地储备，权益拿地金额排名第一 公司在加快存量项目去化的同时，积极补充土地储备，避免可售货值和库 存质量下降。公司在二季度把握结构性机会，聚焦市场表现稳定、竞争优 | 核心要点： | | --- | ❑ 业绩：25H1 收入和业绩承压，毛利率较去年全年回升 公司评级：买入（维持） 近十二个月公司表现 % 1 个月 3 个月 12 个月 相对收益 -7 -11 -26 绝对收益 1 5 9 -10% 0% 10% 20% 30% 40 ...

2025 年 8 月 26 日 公司研究 海外业务稳步增长，扣非业绩表现亮眼 ——山推股份（000680.SZ）2025 年中报点评 要点 事件：公司发布 2025 年中报。2025 年上半年，公司实现营业收入 70.0 亿元， 同比增长 3.0%（追溯调整后，下同）；归母净利润 5.7 亿元，同比增长 8.8%； 扣非归母净利润 5.6 亿元，同比增长 36.5%。2025 年 Q2，公司实现营收 37.0 亿元，同比增长 3.2%，环比增长 12.2%，归母净利润 3.0 亿元，同比增长 4.7%， 环比增长 8.4%，扣非归母净利润 2.9 亿元，同比增长 44.3%，环比增长 7.9%。 点评： 营收平稳增长，扣非净利润表现亮眼：25 年 H1，公司营业收入在经历 24 年同 期营收高增长后增速逐步回稳，完成 2025 全年营收目标（157 亿元）的 45%， 其中海外业务收入 39 亿元，同比增长 7.7%，全年收入目标（90 亿元）完成约 43%；费用端，25 年 H1 期间费率约 9.9%，同比提升 0.2pct，主要因销售激励 增加等导致销售薪酬增长，销售费用同比增加 31%；利润端，公司归母 ...

2025 年 08 月 26 日 比依股份(603215.SH) Q2 收入增长向好，盈利能力短期承压 事件：比依股份公布 2025 年半年度公告。公司 2025H1 实现收 入 11.6 亿元，YoY+34.5%；实现归母净利润 0.5 亿元，YoY-21.0%。 经折算，Q2 单季度实现收入 6.3 亿元，YoY+16.1%；实现归母净 利润 0.4 亿元，YoY-33.1%。展望后续，随着公司持续深耕老客户 及拓展新客户，收入有望保持快速增长。 Q2 公司收入实现较快增长：为了应对美国关税政策的风险，公 司一方面快速推进泰国厂区投产落地，另一方面抓住关税缓冲期 充分发挥交付优势。我们判断 2025Q2 公司空气炸锅收入实现稳健 增长。根据公司公告，公司重点研发项目咖啡机已进一步获得客 户订单和项目合作意向，尤其是全自动机型获得 SharkNinja 的意 向订单。我们分析 2025Q2 公司咖啡机收入快速增长。 Q2 盈利能力同比下降：Q2 公司归母净利率同比-4.5pct。Q2 公 司净利率下降主要原因包括：1）受小家电代工行业竞争较为激烈、 毛利率较低的咖啡机收入占比提升等因素影响，Q2 公司整体毛 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company's performance in the first half of 2025 showed a decline in revenue and net profit, primarily due to increased competition in the API and formulation business, as well as price impacts from centralized procurement [5] - The CDMO business is expected to drive future growth, with a significant increase in ongoing projects and revenue [5] - The company is focusing on stabilizing its formulation business and has completed several key product approvals, which are anticipated to contribute positively to future revenue [5] Financial Performance Summary - For 2023A, the company reported revenue of 11,474 million yuan, with a year-on-year growth rate of 8.81% [2] - The projected revenue for 2025E is 12,815 million yuan, with a growth rate of 6.59% [2] - The net profit for 2023A was 1,055 million yuan, with a year-on-year growth rate of 6.69% [2] - The projected net profit for 2025E is 1,119 million yuan, with a growth rate of 8.55% [2] Business Segment Analysis - The API intermediate segment reported a revenue of 3,603 million yuan in 2025H1, down 23.41% year-on-year [5] - The CDMO segment showed a revenue increase of 20.32% in 2025H1, reaching 1,236 million yuan [5] - The formulation segment generated revenue of 583 million yuan in 2025H1, a decrease of 14.2% year-on-year [5] Future Projections - The company expects revenues of 12,815 million yuan, 14,218 million yuan, and 15,941 million yuan for the years 2025, 2026, and 2027 respectively, with year-on-year growth rates of 6.6%, 11.0%, and 12.1% [5] - The projected net profit for the same years is 1,119 million yuan, 1,270 million yuan, and 1,462 million yuan, with growth rates of 8.55%, 13.50%, and 15.06% respectively [5]

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [2] Core Views - The company has a significant advantage in customer resources and strategically locates its production capacity close to downstream customers [7] - The company has established joint ventures with international partners, enhancing its market presence and technological capabilities [7] - The company has a well-structured layout with 16 production bases across various regions, ensuring timely response and supply to major manufacturers [7] - The forecasted net profit for 2025-2027 is expected to be 5.31 billion, 6.37 billion, and 7.71 billion respectively, with corresponding PE ratios of 10.8, 9.0, and 7.4 [7] Financial Performance Summary - For the first half of 2025, the company achieved revenue of 2.78 billion, a year-on-year increase of 17.18%, while the net profit attributable to shareholders was 216 million, a year-on-year decline of 15.63% [7] - The gross margin for the first half of 2025 was 15.40%, down by 2.76 percentage points year-on-year [7] - The company’s revenue projections for the next few years are as follows: 2023A at 4,599 million, 2024A at 5,667 million, 2025E at 6,526 million, 2026E at 7,663 million, and 2027E at 9,036 million [6][8] - The net profit projections are: 2023A at 546 million, 2024A at 425 million, 2025E at 531 million, 2026E at 637 million, and 2027E at 771 million [6][8] - The company’s EPS is projected to be 1.44 in 2023, 1.12 in 2024, 1.40 in 2025, 1.67 in 2026, and 2.03 in 2027 [6][8]

消费电子稳健增长，AI 算力&汽车打开增量空间 消费电子 立讯精密（002475.SZ） 证券研究报告/公司点评报告 2025 年 08 月 26 日 | 买入（维持） | 评级： | 公司盈利预测及估值 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：王芳 | | 营业收入（百万元） | 231,905 | 268,795 | 310,086 | 372,100 | 427,900 | | | | 增长率 yoy% | 8% | 16% | 15% | 20% | 15% | | 执业证书编号：S0740521120002 | | 归母净利润（百万元） | 10,953 | 13,366 | 16,774 | 19,737 | 22,714 | | Email：wangfang02@zts.com.cn | | 增长率 yoy% | 20% | 22% | 26% | 18% | 15% | | | | 每股收益（元） ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of 5% to 15% over the next six months [12][18]. Core Insights - In H1 2025, the company achieved revenue of 562 million yuan, a year-on-year decrease of 7.35%, with a net profit attributable to shareholders of 45 million yuan, down 28.45% year-on-year [1]. - In Q2 2025, the company reported revenue of 331 million yuan, a year-on-year decrease of 5.59%, but a quarter-on-quarter increase of 43.51%. The net profit attributable to shareholders was 31 million yuan, down 27.79% year-on-year, but up 132.44% quarter-on-quarter [1][2]. Summary by Sections Revenue and Profitability - The company’s sponge zirconium sales (including nuclear-grade zirconium) reached nearly 1,400 tons in H1 2025, with a market share exceeding 50%. The demand for nuclear-grade zirconium is expected to rise due to ongoing nuclear power construction in China, with an anticipated new installed capacity of about 6GW in 2025 [2][3]. Industry Developments - The global sponge zirconium market is experiencing steady growth, with an improved supply-demand balance. The company has signed sales contracts for nuclear-grade sponge zirconium with domestic and overseas clients, leading to bulk shipments [2][3]. Technological Advancements - The company has made significant progress in the industrialization of zirconium and hafnium separation, with plans to establish a separation project that will add an annual production capacity of 20,000 tons of zirconium and hafnium products [3]. Product Development - The company has successfully supplied small batches of solid-state electrolyte materials, utilizing self-produced zirconium chloride as a core raw material. Additionally, it is actively exploring developments in the humanoid robotics industry [4]. Financial Forecast - The company’s net profit forecasts for 2025-2027 are 153 million yuan, 304 million yuan, and 414 million yuan, respectively, with corresponding price-to-earnings ratios of 77.09X, 38.76X, and 28.39X [4][5].